Cat: IPD-X41501

Recombinant Human JMJD8 Protein ,His & Myc

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    JMJD8

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    (Jumonji domain-containing protein 8)

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    N- His & C- Myc

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q96S16

  • 表达区间

    24-264aa

  • 分子量

    34.8 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

JMJD8 (Jumonji domain-containing protein 8) is a member of the Jumonji C (JmjC) domain-containing family of proteins, which are known for their role as histone demethylases, regulating gene expression through epigenetic modifications. The research on JMJD8 has garnered interest due to its involvement in various biological processes, including cellular differentiation, development, and response to stress. Recent studies have suggested that JMJD8 is implicated in the regulation of key signaling pathways and may play a role in specific diseases, including cancer and metabolic disorders. The ability of JMJD8 to modify histones and other substrates positions it as a potential therapeutic target, making the understanding of its structure and function crucial. Recombinant JMJD8 protein production allows researchers to investigate its biochemical properties, binding interactions, and functional mechanisms in detail. By utilizing advanced techniques such as crystallography and mass spectrometry, scientists aim to uncover the precise role of JMJD8 in cellular processes and its potential implications in disease. This research not only adds to the fundamental knowledge of epigenetic regulators but also explores the therapeutic possibilities of targeting JMJD8 in disease management.

客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US